138 related articles for article (PubMed ID: 23461612)
1. Immunological studies of reactive oxygen species damaged catalase in patients with systemic lupus erythematosus: correlation with disease activity index.
Al-Shobaili HA; Al Robaee AA; Alzolibani AA; Rasheed Z
Immunol Invest; 2013; 42(3):191-203. PubMed ID: 23461612
[TBL] [Abstract][Full Text] [Related]
2. Immunological studies of oxidized superoxide dismutase in patients with systemic lupus erythematosus. Correlation with disease induction and progression.
Al-Shobaili HA; Rasheed Z
Saudi Med J; 2012 Nov; 33(11):1177-84. PubMed ID: 23147873
[TBL] [Abstract][Full Text] [Related]
3. Physicochemical and immunological studies on mitochondrial DNA modified by peroxynitrite: implications of neo-epitopes of mitochondrial DNA in the etiopathogenesis of systemic lupus erythematosus.
Al-Shobaili HA; Rasheed Z
Lupus; 2013 Sep; 22(10):1024-37. PubMed ID: 23884988
[TBL] [Abstract][Full Text] [Related]
4. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus.
Morgan PE; Sturgess AD; Davies MJ
Arthritis Rheum; 2005 Jul; 52(7):2069-79. PubMed ID: 15986354
[TBL] [Abstract][Full Text] [Related]
5. Increased levels of autoantibodies against catalase and superoxide dismutase associated with oxidative stress in patients with rheumatoid arthritis and systemic lupus erythematosus.
Mansour RB; Lassoued S; Gargouri B; El Gaïd A; Attia H; Fakhfakh F
Scand J Rheumatol; 2008; 37(2):103-8. PubMed ID: 18415766
[TBL] [Abstract][Full Text] [Related]
6. Impact of anti-peroxynitrite-damaged-thymidine-monophosphate antibodies on disease activity in patients with systemic lupus erythematosus.
Alghasham A; Al Salloom AA; Alghamadi AS; Rasheed Z
Nucleosides Nucleotides Nucleic Acids; 2015; 34(1):56-68. PubMed ID: 25513864
[TBL] [Abstract][Full Text] [Related]
7. Markers of oxidative and nitrosative stress in systemic lupus erythematosus: correlation with disease activity.
Wang G; Pierangeli SS; Papalardo E; Ansari GA; Khan MF
Arthritis Rheum; 2010 Jul; 62(7):2064-72. PubMed ID: 20201076
[TBL] [Abstract][Full Text] [Related]
8. Anti-lipoprotein lipase antibodies: a new player in the complex atherosclerotic process in systemic lupus erythematosus?
de Carvalho JF; Borba EF; Viana VS; Bueno C; Leon EP; Bonfá E
Arthritis Rheum; 2004 Nov; 50(11):3610-5. PubMed ID: 15529371
[TBL] [Abstract][Full Text] [Related]
9. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity.
Aggarwal R; Sequeira W; Kokebie R; Mikolaitis RA; Fogg L; Finnegan A; Plaas A; Block JA; Jolly M
Arthritis Care Res (Hoboken); 2011 Jun; 63(6):891-8. PubMed ID: 21312346
[TBL] [Abstract][Full Text] [Related]
10. Anti-CD43 and anti-galectin-1 autoantibodies in patients with systemic lupus erythematosus.
Montiel JL; Monsiváis-Urenda A; Figueroa-Vega N; Moctezuma JF; Burgos-Vargas R; González-Amaro R; Rosenstein Y
Scand J Rheumatol; 2010; 39(1):50-7. PubMed ID: 20132071
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies against monomeric C-reactive protein in sera from patients with lupus nephritis are associated with disease activity and renal tubulointerstitial lesions.
Tan Y; Yu F; Yang H; Chen M; Fang Q; Zhao MH
Hum Immunol; 2008 Dec; 69(12):840-4. PubMed ID: 18852001
[TBL] [Abstract][Full Text] [Related]
12. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P
Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus.
Husebye ES; Sthoeger ZM; Dayan M; Zinger H; Elbirt D; Levite M; Mozes E
Ann Rheum Dis; 2005 Aug; 64(8):1210-3. PubMed ID: 15708887
[TBL] [Abstract][Full Text] [Related]
14. Significance of Lipid-Derived Reactive Aldehyde-Specific Immune Complexes in Systemic Lupus Erythematosus.
Wang G; Pierangeli SS; Willis R; Gonzalez EB; Petri M; Khan MF
PLoS One; 2016; 11(10):e0164739. PubMed ID: 27749917
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
[TBL] [Abstract][Full Text] [Related]
16. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.
Pradhan VD; Patwardhan MM; Ghosh K
Indian J Dermatol Venereol Leprol; 2010; 76(2):145-9. PubMed ID: 20228543
[TBL] [Abstract][Full Text] [Related]
17. Anti-nucleosome antibodies as a disease activity marker in patients with systemic lupus erythematosus.
Suleiman S; Kamaliah D; Nadeem A; Naing NN; Che Maraina CH
Int J Rheum Dis; 2009 Jul; 12(2):100-6. PubMed ID: 20374326
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus.
Sjöwall C; Bengtsson AA; Sturfelt G; Skogh T
Arthritis Res Ther; 2004; 6(2):R87-94. PubMed ID: 15059271
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease.
Reichlin M; Broyles TF; Hubscher O; James J; Lehman TA; Palermo R; Stafford HA; Taylor-Albert E; Wolfson-Reichlin M
Arthritis Rheum; 1999 Jan; 42(1):69-75. PubMed ID: 9920016
[TBL] [Abstract][Full Text] [Related]
20. Association of biological markers of activity of systemic lupus erythematosus with levels of anti-oxidized low-density lipoprotein antibodies.
Gómez-Zumaquero JM; Tinahones FJ; De Ramón E; Camps M; Garrido L; Soriguer FJ
Rheumatology (Oxford); 2004 Apr; 43(4):510-3. PubMed ID: 14872100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
